A SERIES OF PATIENTS (PTS) WITH RECURRENT GBM (rGBM) TREATED WITH ABT-414, BEVACIZUMAB (BEV) AND CCNU

De Silva, M; Lee, A; Kastela, M; Wheeler, H; Khasraw, M

NEURO-ONCOLOGY, 2019; 21 (): 19